Dr. Janjua provides leadership on surveillance, research and policy advice and programing related to hepatitis B and C in British Columbia. His research interests include hepatitis B and C, syndemics of substance use, mental illness and blood-borne infections, intervention effectiveness, health disparities and strategies to enhance access to care.

Brendan is a postdoctoral fellow undertaking research in hepatitis C virus infection, health service utilisation, and patterns of substance use in vulnerable populations. With a background in laboratory research, Brendan is now gaining experience in substance use and addiction epidemiology.

Behzad Hajari is a clinical epidemiologist, and a Senior Lecturer in the Kirby Institute, University of New South Wales, Sydney. He trained as a Medical Practitioner and has an MPH and PhD in Medicine. His research interests include HCV care in prison setting and among people who inject drugs.

Professor Dore is Head, Viral Hepatitis Clinical Research Program, Kirby Institute, UNSW Sydney, and Infectious Diseases Physician, St Vincent's Hospital, Sydney.

Julie Holeksa received a B.A in Sociology and an M.Sc in Global Health and Public Policy. She is currently researching the treatment of HCV in vulnerable populations.

Claudia Bernardini is an internal medicine and infectious disease specialist and has worked as physician at Arud in Zurich, Switzerland since 2017. Her main focus of research and care is in HIV and hepatitis. She has mainly published within the framework of the Swiss HIV Cohort Study (SHCS).